about
Advanced techniques using contrast media in neuroimagingPrehospital stroke scales as screening tools for early identification of stroke and transient ischemic attackThrombolysis for acute ischaemic strokeOral antiplatelet therapy for acute ischaemic strokePercutaneous vascular interventions for acute ischaemic strokeMagnetic resonance imaging versus computed tomography for detection of acute vascular lesions in patients presenting with stroke symptomsThrombolysis for acute ischaemic strokeAntiplatelet therapy for acute ischaemic strokeAntiplatelet therapy for acute ischaemic strokeDehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental strokeRecombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisThe goldilocks dilemma in acute ischemic strokeNeuroprotection for ischemic stroke: past, present and futureOutcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or olderSulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic strokeUse of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trialsThe Ischemic Stroke Genetics Study (ISGS) Protocol.Simplified Acute Physiology Score III: a project for a new multidimensional tool for evaluating intensive care unit performanceKnowledge and perception about stroke among an Australian urban populationArterial indications for the low molecular weight heparinsLeft ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic strokeRural community knowledge of stroke warning signs and risk factors.Minor Stroke and Transient Ischemic Attack: Research and PracticeAdaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbationsA Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral IschemiamHealth For Aging China: Opportunities and ChallengesMechanical Thrombectomy Is Now the Gold Standard for Acute Ischemic Stroke: Implications for Routine Clinical PracticeThe transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in strokeImpacts of tissue-type plasminogen activator (tPA) on neuronal survivalEffectiveness of regionalized systems for stroke and myocardial infarctionEndovascular Recanalization Therapy in Acute Ischemic Stroke: Updated Meta-analysis of Randomized Controlled TrialsChoosing a Hyperacute Stroke Imaging Protocol for Proper Patient Selection and Time Efficient Endovascular Treatment: Lessons from Recent TrialsPrevious and Recent Evidence of Endovascular Therapy in Acute Ischemic StrokeTissue-type plasminogen activator is a neuroprotectant in the central nervous systemCombined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic strokeWhat to do With Wake-Up StrokeManagement of Postthrombolysis Hemorrhagic and Orolingual Angioedema ComplicationsWhat is the Role for Intra-Arterial Therapy in Acute Stroke Intervention?Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset
P2860
Q22252349-676B6F84-1EE2-4AD2-860A-7CB5174C836AQ24187522-7E81A5A4-6D39-4AE8-8A68-EB354AA86E05Q24194788-EB1E52E3-EC7D-419F-B388-02FF975394F4Q24197866-1D9CD75D-E870-4F0A-BC1D-37AA57E2CAEFQ24234478-2910301B-8184-459F-BF9B-389823437D65Q24239967-8B1CB1BB-A9D0-4D65-8216-46CCD2972778Q24240067-A740F470-4D00-44D9-82D7-C0EDF6243BC1Q24242725-6363425B-3503-4914-83C1-239443151AA9Q24248787-9DB6224E-060A-437C-A54F-EDA5D581CD23Q24555180-2B762E16-E23A-437B-9D10-C5E0196F8E03Q24595703-DD3E6C28-31B5-491E-85A0-48E5B0BD8AF2Q24607568-6A492150-4D9D-4F6E-8520-31EEFA0064F4Q24645185-53825BD2-67AE-4440-B338-7460041E02FBQ24646395-A68E71EF-52E4-417F-80B3-8AAE92A34DE2Q24656127-86AD600E-DA3D-4DF7-964A-92BC82A49D95Q24793478-F2CEDF4A-0971-4948-B36F-BD6A3AB3B7B1Q24794936-C21A6406-0E0E-4658-B980-5E9046A78AF9Q24795743-536DE52F-6C81-4F32-81FF-62290E7B2617Q24796154-B510AB14-F689-4B37-9C55-DB5BDCDA1828Q24806932-143A1421-1D4B-4974-8372-3A24495F9F43Q24811278-D269009C-609C-42F3-8BE6-4C95A38D7423Q25255242-11833C19-D1D2-49C8-9381-09FC5290BD36Q26745201-3B5FFF82-8C4E-4D39-8308-D0F312D0ACAEQ26765956-4B5E23AF-879A-4AA5-85AC-E2A9947E9B12Q26772837-4DAC4704-5EEE-4D94-A874-8926E0F38C67Q26773996-98B37837-90BE-4EB4-9BA6-7DBD6057668EQ26776269-E6AD4B8F-D4D5-4EF6-B4E4-6765D142DE4BQ26776379-CAE7133C-F868-421E-A51B-A3D86FCEDE1DQ26777261-F712D3D7-1749-4253-B3CE-9AADB1B6C03DQ26777840-9DCDD1D5-C86A-43C7-A2FC-6EDA06427E91Q26781917-566595A6-DE6E-4148-B754-6F2475FEE5C8Q26781934-FDD2C4B1-0984-40E0-B75C-7BC1F2AE5B30Q26782864-D4D993A1-2684-4380-A6A3-2BCC78BCDE72Q26782904-D35F11D1-88CA-4D45-9DA5-F2349F4345B1Q26782990-FACA60A1-EFD8-4D4E-A132-ACA73245272AQ26796464-44316D84-B6FA-453B-813C-17C3714BF1B4Q26796470-E0706D65-3E17-4F1B-B92C-F7797FF7D25AQ26796472-3471DE21-4640-4FF5-9EE6-CC1AEBEA8739Q26796474-33D015F3-059F-447F-A6DA-C663346536F3Q26796477-A3CD66E0-8384-4E2F-A286-7643BFD2AD1D
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Tissue plasminogen activator for acute ischemic stroke
@ast
Tissue plasminogen activator for acute ischemic stroke
@en
type
label
Tissue plasminogen activator for acute ischemic stroke
@ast
Tissue plasminogen activator for acute ischemic stroke
@en
prefLabel
Tissue plasminogen activator for acute ischemic stroke
@ast
Tissue plasminogen activator for acute ischemic stroke
@en
P3181
P1476
Tissue plasminogen activator for acute ischemic stroke
@en
P304
P3181
P356
10.1056/NEJM199512143332401
P407
P577
1995-12-14T00:00:00Z